Newsletter Subject

Program Update & Registration Reminder: MedTech 8-9 Quebec Canada

From

optica.org

Email Address

industry@opticacommunications.org

Sent On

Wed, Aug 28, 2024 04:16 AM

Email Preheader Text

8-9 October 2024 Quebec, Canada Dear {NAME}, MORE THAN 35 medical industry leaders will present thei

8-9 October 2024 Quebec, Canada Dear {NAME}, MORE THAN 35 medical industry leaders will present their insights and strategies for getting photonics-enabled products to market. We invite you to [REGISTER](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) to reserve your place in this highly interactive program. Every attendee can expect to gain meaningful business-building knowledge and connections that are critical to success. Content and Connections... The MedTech Program Features Networking Welcome Dinner, Group Breakfast, Session Breaks, and Meals, Reception Keynotes John Sheets, Dimitrios Angelis, Lori Arakakin, Matteo Negro, Petteri Uusimaa Session Topics Photonic Devices for Medical Imaging and Diagnosis Photonics Devices for Medical Treatment and Therapy Miniaturization of Photonics Devices and Wearables Photonics in Surgery and Rehabilitation The Future of Medical Devices Tour Exclusive CHUM Research Center tour Facilitated Introductions Optica staff will help you connect during and after the Summit [Register Online](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Dates: 8-9 October, 2024 Location: CHUM de Montreal, Quebec, Canada The Presenters... MedTech Summit Presenters (in the order pictured above) (Row One) [John Fengler](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Sr. Director, R&D, Stryker [Philippe Lapierre](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Business Development Manager, CLEIO [Ludovic Live](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) CEO & Co-Founder, Affinité Instruments [John Sheets](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) CEO, Pantheon Vision [Caroline Boudoux](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Co-Founder & Co-President, Castor [Dimitrios Angelis](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) CEO, Co-Founder & President, Sparta Biomedical [François Thériault-Proulx](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) CEO, Medscint [Tuba Yamaç](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r)6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r Partner, Patent Agent at BCF (Row Two) [François Daoust](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Co-founder, Exclaro [Matteo Negro](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) CEO, Cambridge Raman Imaging Ltd [Petteri Uusimaa](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Vice President & CTO, Modulight [Michael Wood](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Principal Scientist, Synaptive Medical [Alexander Weil](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Assoc Neurosurgeon, U of Montreal Hospital Ctr, CHUM [Lori Arakaki](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Co-Founder and CEO, Opticye (Row Three) [Reinhard Voelkel](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) CEO, Focuslight Switzerland [Louis-Philippe Pleau](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) President & CEO, LumIR Lasers [Bjorn Manuel Hegelich](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) CEO & Founder, TAU Systems [Amanda Amori Faltyn](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Vice President of Sales, HUBNER Photonics, Inc [Shlomo Assa](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) President & Co-Founder, Acclaro Corpo [Gabriel Rivest](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Board Advisor, Reveal Surgical [Patrick Sauvageau](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Co-Founder and CEO, Zilia Health [Sebastian Hülck](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) CEO, Tec5USA (Row Four) [Jean-Philippe Sylvestre](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r)6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r Chief R&D, Opitna Diagnostics [Ioanna Zergioti](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) CEO & Co-Founder, PhosPrint [Maroun Massabki](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) General Director, Optech [Nick Reder](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) CEO, Alpenglow Biosciences [Jonas Leuermann](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) CEO, Bioherent [Jose Pozo](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Chief Technology Officer, Optica [Robert Brown](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Technical Director of Business Development, INO [Joe Delfino](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) VP of Sales & Business Development. FISBA (Row Five) [Daniel Côté](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Chief Scientist/Professor, Bliq Photonics/CERVO Research Center [Wouter Charle](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Program Manager, IMEC [Fred Saad](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Professor, University of Montreal [Emilio Alarcon](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Assoc Professor & Principal Investigator, U of Ottawa [Frederic Leblond](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r)6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r Professor, Polytechnique Montreal [Brian Wilson](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Senior Scientist and Professor, University of Toronto [Vincent Poitout](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) Directeur, CRCHUM Let's Get New Photonics-Enabled Products to Market and Save Lives The [Speakers](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) and [Program](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) will address the full range of issues medical device manufacturers must navigate from start to finish. Come to the meeting and connect directly with developers, potential collaborators, and industry advisors. This Summit is dedicated to facilitating crucial connections, and delivering practical strategies for expediting photonics innovations to the healthcare market. We look forward to your participation! Sincerely, Jose Dr. Jose Pozo CTO, Optica Become a MedTech Sponsor! Contact Alicia Jensen (ajensen@optica.org) to discuss business-building sponsorship opportunities. Hosted by: 6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r Global Headquarters 2010 Massachusetts Ave. NW Washington, DC 20036 USA +1 202.416.1907 · custserv@optica.org · [optica.org](6z43sFwNS:m:1:2647670365:FA1EF4768FCE8E3C010546030B737E10:r) This message has been sent to {EMAIL}. [Unsubscribe from all Optica Emails](

Marketing emails from optica.org

View More
Sent On

01/10/2024

Sent On

09/09/2024

Sent On

03/09/2024

Sent On

10/01/2024

Sent On

19/12/2023

Sent On

30/10/2023

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.